Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference10 articles.
1. CNS drug development: lessons from the development of ondansetron, aprepitant, ramelteon, varenicline, lorcaserin, and suvorexant. Part I;Preskorn;J Psychiatr Pract,2014
2. CNS drug development: lessons learned part 2: symptoms, not syndromes as targets consistent with the NIMH research domain approach;Preskorn;J Psychiatr Pract,2015
3. CNS drug development: lessons learned part 3: psychiatric and central nervous system drugs developed over the last decade—implications for the field;Preskorn;J Psychiatr Pract,2017
4. CNS drug development, lessons learned, part 4: the role of brain circuitry and genes—tasimelteon as an example;Preskorn;J Psychiatr Pract,2017
5. CNS drug development. Part I: the early period of CNS drugs;Preskorn;J Psychiatr Pract,2010
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献